Browsing University of Galway Support Services by Subject "urological oncology"
Now showing items 1-1 of 1
-
Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical chart review across ten centers in five european countries
(Wiley-Blackwell, 2014-07-18)Angiogenesis inhibitors have become standard of care for advanced and/or metastatic renal cell carcinoma (RCC), but data on the impact of adverse events (AEs) and treatment modifications associated with these agents are ...